Tokyo, May 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061730) titled 'Perioperative treatment patterns and outcomes by risk of recurrence for patients with HER2-positive early breast cancer; A retrospective database study in Japan' on May 30.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Daiichi Sankyo Co., Ltd.
Condition:
Condition - HER2 positive breast cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To use a database to assess the implementation and efficacy of perioperative treatment for HER2-positive breast cancer patients stratified by disease stage
Basic objectives2 - Others
Eligibility:
Age-low...